Protective role of estrogen against excessive erythrocytosis in Monge's disease.
Protective role of estrogen against excessive erythrocytosis in Monge's disease.
复制标题
DOI:
10.1038/s12276-020-00550-2
复制
发表时间:
2021-01
影响因子:
12.8
通讯作者:
Haddad GG
中科院分区:
文献类型:
--
作者:
Azad P;Villafuerte FC;Bermudez D;Patel G;Haddad GG
Monge’s disease (chronic mountain sickness (CMS)) is a maladaptive condition caused by chronic (years) exposure to high-altitude hypoxia. One of the defining features of CMS is excessive erythrocytosis with extremely high hematocrit levels. In the Andean population, CMS prevalence is vastly different between males and females, being rare in females. Furthermore, there is a sharp increase in CMS incidence in females after menopause. In this study, we assessed the role of sex hormones (testosterone, progesterone, and estrogen) in CMS and non-CMS cells using a well-characterized in vitro erythroid platform. While we found that there was a mild (nonsignificant) increase in RBC production with testosterone, we observed that estrogen, in physiologic concentrations, reduced sharply CD235a+ cells (glycophorin A; a marker of RBC), from 56% in the untreated CMS cells to 10% in the treated CMS cells, in a stage-specific and dose-responsive manner. At the molecular level, we determined that estrogen has a direct effect on GATA1, remarkably decreasing the messenger RNA (mRNA) and protein levels of GATA1 (p < 0.01) and its target genes (Alas2, BclxL, and Epor, p < 0.001). These changes result in a significant increase in apoptosis of erythroid cells. We also demonstrate that estrogen regulates erythropoiesis in CMS patients through estrogen beta signaling and that its inhibition can diminish the effects of estrogen by significantly increasing HIF1, VEGF, and GATA1 mRNA levels. Taken altogether, our results indicate that estrogen has a major impact on the regulation of erythropoiesis, particularly under chronic hypoxic conditions, and has the potential to treat blood diseases, such as high altitude severe erythrocytosis. The hormone estrogen protects against chronic mountain sickness (CMS) in pre-menopausal women and may prove valuable in treating the condition. People who live for years in high altitude mountain regions are susceptible to CMS because of prolonged oxygen deprivation. One factor in CMS is an over-production of red blood cells, thickening the blood and increasing the risk of strokes and cardiovascular diseases. Men are more likely to suffer CMS than women, although cases spike in females after menopause. Gabriel Haddad at the University of California in San Diego, USA, and co-workers used a cell culture model of CMS to demonstrate that estrogen provides protection against the disease. Estrogen significantly alters the expression and activity of red blood cell-related genes to regulate red blood cell levels by controlling cell death mechanisms.
登录
查看更多内容
DOI:
10.1084/jem.20151920
发表时间:
2016-11-14
期刊:
The Journal of experimental medicine
影响因子:
--
作者:
Azad P;Zhao HW;Cabrales PJ;Ronen R;Zhou D;Poulsen O;Appenzeller O;Hsiao YH;Bafna V;Haddad GG
通讯作者:
Haddad GG
影响因子:
9.6
作者:
De Ferrari, Aldo;Miranda, J. Jaime;Checkley, William
通讯作者:
Checkley, William
DOI:
10.1152/ajpendo.00184.2014
发表时间:
2014-09-01
影响因子:
5.1
作者:
Beggs, Luke A.;Yarrow, Joshua F.;Borst, Stephen E.
通讯作者:
Borst, Stephen E.
影响因子:
2.6
作者:
Beall, CM
通讯作者:
Beall, CM
影响因子:
3.7
作者:
Eichstaedt CA;Antão T;Pagani L;Cardona A;Kivisild T;Mormina M
通讯作者:
Mormina M